Diagnosis and management of acute otitis media in the urgent care setting

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Rising otitis media prevalence impacts healthcare utilization, particularly in urgent care.
• Antibiotic resistance in key pathogens like Streptococcus pneumoniae complicates acute otitis media (AOM) management.
• Beta-lactamase production by Haemophilus influenzae and Moraxella catarrhalis is a concern, but S. pneumoniae resistance is a greater clinical challenge.

Purpose of the Study:

• To present evidence-based recommendations for AOM treatment in the context of widespread antibiotic resistance.
• To guide practitioners in urgent care settings on selecting appropriate antimicrobial therapy for AOM.
• To address the challenge of treating AOM caused by penicillin-resistant Streptococcus pneumoniae.

Main Methods:

• Convening of the Drug-Resistant S. pneumoniae Therapeutic Working Group by the CDC.
• Development of evidence-based treatment guidelines for AOM.
• Review of antimicrobial agents and their efficacy against resistant bacterial strains.

Main Results:

• Amoxicillin is recommended as the preferred first-line agent for AOM.
• Higher dosages of amoxicillin (up to 90 mg/kg/day) are suggested for specific patient populations.
• For treatment failures after 3 days, options include high-dose amoxicillin-clavulanate, clindamycin, cefuroxime axetil, or intramuscular ceftriaxone.

Conclusions:

• The updated guidelines provide a framework for managing AOM in an era of increasing antibiotic resistance.
• Practitioners can utilize these principles to optimize therapeutic decisions in urgent care settings.
• Effective management of AOM requires consideration of pathogen resistance patterns and appropriate antibiotic selection.